Back to Top
Go Back
Journal Photo for Indo Global Journal of Pharmaceutical Sciences
Peer reviewed only Open Access

Indo Global Journal of Pharmaceutical Sciences (IGJPS)

Publisher : iGlobal Research and Publishing Foundation
pharmaceutical sciences pharmacy Pharmacology
Claim Your Journal Get PRC Visit Website
e-ISSN 2249-1023
Issue Frequency Quarterly
Est. Year 2011
Mobile 9818603719
DOI YES
Country India
Language English
APC YES
Impact Factor Assignee Google Scholar
Email editor@iglobaljournal.com

Journal Descriptions

IGJPS is an international journal online. It is interdisciplinary and aims to bring together different approaches for a diverse readership all over the world in pharmaceutical sciences. This Journal publishes original research work that contributes significantly to further the scientific knowledge in pharmacy and pharmaceutical sciences (Pharmaceutical Technology, Pharmacognosy, Natural Product Research, Pharmaceutics, Novel Drug Delivery, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest). The Journal publishes original research work either as a Full Research Paper or as a Short Communication. Review Articles on a current topic in the said fields are also considered for publication by the Journal.

Indo Global Journal of Pharmaceutical Sciences (IGJPS) is :-

  • International, Peer-Reviewed, Open Access, Refereed, pharmaceutical sciences, pharmacy, Pharmacology, Toxicology, Pharmaceutics , Online , Quarterly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2249-1023, Established: 2011,
  • Provides Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of IGJPS

Directly Compressible Sustained Release Matrix Tablets of Losartan Potassium via Crystallo-co-agglomeration
Mehul Patel April, 2023
Background: Losartan potassium possesses poor bioavailability due to low elimination half-life and so requires to be developed as sustained release dosage form. Objectives: The present study...